Relay Therapeutics (RLAY) News Today $4.11 -0.03 (-0.61%) As of 03:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RLAY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Relay Therapeutics, Inc. $RLAY Shares Sold by Goldman Sachs Group Inc.September 17 at 3:46 AM | marketbeat.comRelay Therapeutics, Inc. $RLAY Shares Purchased by Acadian Asset Management LLCSeptember 17 at 3:17 AM | marketbeat.comRelay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10, 2025 | seekingalpha.comTrexquant Investment LP Lowers Holdings in Relay Therapeutics, Inc. $RLAYSeptember 9, 2025 | marketbeat.comRelay Therapeutics (RLAY) Receives a Buy from GuggenheimSeptember 9, 2025 | theglobeandmail.comParkman Healthcare Partners LLC Sells 312,496 Shares of Relay Therapeutics, Inc. $RLAYSeptember 8, 2025 | marketbeat.comInvesco Ltd. Has $484,000 Position in Relay Therapeutics, Inc. $RLAYSeptember 8, 2025 | marketbeat.comGuggenheim Gives Buy Rating to Relay Therapeutics (RLAY)September 8, 2025 | insidermonkey.comOMERS ADMINISTRATION Corp Makes New Investment in Relay Therapeutics, Inc. $RLAYSeptember 7, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Research Coverage Started at GuggenheimSeptember 7, 2025 | americanbankingnews.comGuggenheim Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY)September 6, 2025 | marketbeat.comWalleye Capital LLC Sells 825,589 Shares of Relay Therapeutics, Inc. $RLAYSeptember 6, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Trading Up 7.6% - What's Next?September 5, 2025 | marketbeat.comGuggenheim assumes Relay with Buy, names best ideaSeptember 4, 2025 | msn.comNuveen LLC Purchases Shares of 320,395 Relay Therapeutics, Inc. $RLAYSeptember 4, 2025 | marketbeat.comRelay Therapeutics assumed with a Buy at GuggenheimSeptember 3, 2025 | msn.comWill Relay Therapeutics (NASDAQ:RLAY) Spend Its Cash Wisely?August 30, 2025 | finance.yahoo.comHC Wainwright Issues Positive Outlook for RLAY EarningsAugust 30, 2025 | marketbeat.comCW Advisors LLC Makes New Investment in Relay Therapeutics, Inc. $RLAYAugust 30, 2025 | marketbeat.comVanguard Group Inc. Reduces Stock Position in Relay Therapeutics, Inc. $RLAYAugust 30, 2025 | marketbeat.comBrokers Offer Predictions for RLAY FY2026 EarningsAugust 29, 2025 | marketbeat.comRelay Therapeutics to Participate in Two Upcoming Investor Conferences in SeptemberAugust 28, 2025 | globenewswire.comRelay Therapeutics (NASDAQ:RLAY) Price Target Cut to $14.00 by Analysts at HC WainwrightAugust 28, 2025 | marketbeat.comRelay Therapeutics price target lowered to $14 from $16 at H.C. WainwrightAugust 27, 2025 | msn.comCandriam S.C.A. Sells 1,149,063 Shares of Relay Therapeutics, Inc. $RLAYAugust 26, 2025 | marketbeat.comLeerink Partners Reiterates a Buy Rating on Relay Therapeutics (RLAY) With a $12 PTAugust 26, 2025 | msn.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 26, 2025 | marketbeat.comRaymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost CutsAugust 18, 2025 | msn.comRelay Therapeutics (RLAY) Gets a Buy from Bank of America SecuritiesAugust 9, 2025 | theglobeandmail.comRelay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Analyst DowngradeAugust 9, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Price Target Lowered to $19.00 at Raymond James FinancialAugust 9, 2025 | marketbeat.comRelay (RLAY) Q2 Loss Narrows 41%August 7, 2025 | fool.comRelay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 7, 2025 | globenewswire.comRelay Therapeutics Q2 2025 Earnings PreviewAugust 7, 2025 | seekingalpha.comPreview: Relay Therapeutics's EarningsAugust 7, 2025 | benzinga.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 8.2% - Here's What HappenedAugust 5, 2025 | marketbeat.comBarclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PTAugust 5, 2025 | msn.comRelay Therapeutics: What's Next For H2 2025?August 2, 2025 | seekingalpha.comBarclays Reiterates a Buy Rating on Relay Therapeutics (RLAY)August 1, 2025 | msn.comInsider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells 4,069 Shares of StockJuly 31, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Insider Peter Rahmer Sells 15,724 SharesJuly 31, 2025 | marketbeat.comInsider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells 18,276 Shares of StockJuly 31, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) CFO Thomas Catinazzo Sells 18,380 SharesJuly 31, 2025 | marketbeat.comDonald A. Bergstrom Sells 26,701 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) StockJuly 31, 2025 | marketbeat.comRelay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025July 31, 2025 | globenewswire.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells $15,218.06 in StockJuly 31, 2025 | insidertrades.comRelay Therapeutics (RLAY) to Release Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comRelay Therapeutics has positive read from Celcuity data, says BarclaysJuly 30, 2025 | finance.yahoo.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 30, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Sees Large Volume Increase - Still a Buy?July 25, 2025 | marketbeat.com Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RLAY Media Mentions By Week RLAY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLAY News Sentiment▼1.720.92▲Average Medical News Sentiment RLAY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLAY Articles This Week▼45▲RLAY Articles Average Week Get the Latest News and Ratings for RLAY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HCM News BHC News OGN News KNSA News CGON News ALVO News CPRX News TARS News IDYA News OCUL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RLAY) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLAY Stock Alerts